Distributional impact of rotavirus vaccination in 25 GAVI countries: Estimating disparities in benefits and cost-effectiveness
Authors:
- Richard RheingansRRRichard Rheingans
- Deborah AtherlyDADeborah Atherly
- John AndersonJAJohn Anderson
Abstract
No abstract availableKeywords
Funding Information
- GAVI Alliance
This publication has 31 references indexed in Scilit:
- Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030Vaccine, 2012
- Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groupsVaccine, 2011
- Rotavirus Disease Burden and Impact and Cost‐Effectiveness of a Rotavirus Vaccination Program in KenyaThe Journal of Infectious Diseases, 2009
- Rotavirus Vaccination: Cost‐Effectiveness and Impact on Child Mortality in Developing CountriesThe Journal of Infectious Diseases, 2009
- Economic Costs of Rotavirus Gastroenteritis and Cost‐Effectiveness of Vaccination in Developing CountriesThe Journal of Infectious Diseases, 2009
- Overcoming Barriers and Ensuring Access to HPV Vaccines in Low-Income CountriesAmerican Journal of Law & Medicine, 2009
- Human papilloma virus vaccine – more than a vaccineCurrent Opinion in Obstetrics and Gynecology, 2007
- Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countriesRevista Panamericana de Salud Pública, 2007
- Projected Cost‐Effectiveness of Rotavirus Vaccination for Children in AsiaThe Journal of Infectious Diseases, 2005
- Measles vaccination improves the equity of health outcomes: evidence from BangladeshHealth Economics, 2002